Sign In
Buy KPTI
$9.00
-0.230 (-2.49%)
At Close: Jun 03, 2026
Fahim Saleh murder suspect 'had difficult childhood' but not violent, aunt says
07:52pm, Sunday, 19'th Jul 2020
THE accused killer of a tech millionaire found butchered and stuffed into bags had a difficult childhood but isn’t violent or incapable of murder, his aunt has said. Tyrese Devon Haspi pleade…
Personal assistant accused of killing his boss had troubled childhood
02:27pm, Sunday, 19'th Jul 2020
Tyrese Haspil, 21, was arrested on Friday and charged with the grisly murder of his boss Fahim Saleh. Haspil's aunt Marjorie Sine expressed her shock over the allegations against him.
Karyopharm's XPOVIO Progress And Other News: The Good, Bad And Ugly Of Biopharma
01:44pm, Sunday, 19'th Jul 2020
Karyopharm collaborates with National Cancer Institute for XPOVIO. ADC Therapeutics advances LOTIS 3 Clinical Trial of Loncastuximab Tesirine.
Advisor Group Holdings Inc. Makes New $333,000 Investment in Karyopharm Therapeutics Inc (NASDAQ:KPTI)
05:01am, Saturday, 18'th Jul 2020
Advisor Group Holdings Inc. bought a new position in shares of Karyopharm Therapeutics Inc (NASDAQ:KPTI) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securi
Karyopharm Therapeutics Inc Expected to Earn Q2 2020 Earnings of ($0.48) Per Share (NASDAQ:KPTI)
01:50am, Saturday, 18'th Jul 2020
Karyopharm Therapeutics Inc (NASDAQ:KPTI) – Investment analysts at SVB Leerink decreased their Q2 2020 earnings per share estimates for shares of Karyopharm Therapeutics in a report issued on Tuesda
Karyopharm Therapeutics (KPTI) Received its Third Buy in a Row - Markets
01:51pm, Friday, 17'th Jul 2020
After RBC Capital and Canaccord Genuity gave Karyopharm Therapeutics (NASDAQ: KPTI) a Buy rating last month, the company received another
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO® (selinexor) Research
11:00am, Friday, 17'th Jul 2020
NEWTON, Mass., July 17, 2020 -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an innovation-driven pharmaceutical company, today announced that it has entered into a Cooperative.
Wells Fargo & Company MN Has $1.22 Million Stock Holdings in Karyopharm Therapeutics Inc (NASDAQ:KPTI)
10:40pm, Wednesday, 15'th Jul 2020
Wells Fargo & Company MN lifted its position in Karyopharm Therapeutics Inc (NASDAQ:KPTI) by 3.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Com
Karyopharm Announces Preliminary Unaudited Second Quarter Product Sales for XPOVIO® (selinexor) | MarketScreener
11:01am, Tuesday, 14'th Jul 2020Karyopharm Announces Preliminary Unaudited Second Quarter Product Sales for XPOVIO® (selinexor)
11:00am, Tuesday, 14'th Jul 2020
\-- Preliminary Unaudited XPOVIO Net Product Sales of Approximately $18.5 Million for the Second Quarter 2020 --\-- Strongest Quarterly XPOVIO Sales Since July 2019 Commercial Launch --NEWTON, Mass.,
-$0.56 EPS Expected for Karyopharm Therapeutics Inc (NASDAQ:KPTI) This Quarter
08:22am, Monday, 13'th Jul 2020
Brokerages expect that Karyopharm Therapeutics Inc (NASDAQ:KPTI) will post earnings per share of ($0.56) for the current quarter, according to Zacks. Six analysts have made estimates for Karyopharm Th
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:05pm, Wednesday, 01'st Jul 2020
Karyopharm Therapeutics Inc. (KPTI), an innovation-driven pharmaceutical company, today announced that the Compensation Committee of Karyopharm’s Board of Directors granted stock options to purchase
2 Biotech Stocks That Could Soar in 2020 | The Motley Fool
11:12am, Wednesday, 01'st Jul 2020
These companies offer promising pipelines that could deliver in the long term.
Wall Street Analysts Are Bullish on Top Healthcare Picks - Markets
10:13am, Wednesday, 01'st Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on G1 Therapeutics
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12:00am, Wednesday, 01'st Jul 2020
NEWTON, Mass., July 01, 2020 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), an innovation-driven pharmaceutical company, today...
